Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The amplification of murine double minutes (MDM2) is the primary feature of well-differentiated liposarcomas (WDLPS) and dedifferentiated liposarcomas (DDLPS), while DDIT3 rearrangement is the main one of myxoid liposarcomas (MLPS). Our aim was to evaluate the added value of MDM2 amplification and DDIT3 rearrangement in making a diagnosis and classifying lipogenic tumors. Methods: Eighty-two cases of liposarcoma and 60 lipomas diagnosed between 1995 and 2010 were analysed for MDM2 amplification and DDIT3 rearrangement using a fluorescence in situ hybridization (FISH). The subtypes of liposarcoma were reclassified according to the molecular results, whose results were reviewed with an analysis of the relevant histologic and immunohistochemical findings. Results: One case of lipoma (1.67%) was reclassified as a WDLPS. Of the liposarcomas, 13.4% (16/82) were reclassified after the molecular testing. Five cases of MLPS were reclassified as four cases of DDLPS and one case of myxoid lipoma. Two cases of WDLPS were reclassified as one case of spindle cell lipoma and another case of myxofibrosarcoma. Four cases of DDLPS were reclassified as two cases of leiomyosarcoma, one case of angiomyolipoma and another case of fibroinflammatory lesion. Of the six cases of pleomorphic liposarcoma, five were reclassified as DDLPS. Conclusions: In our series, a critical revision of diagnosis was found at a rate of 3.5% (5/142) after a review of the lipomatous lesions. The uses of molecular testing by MDM2 and DDIT3 FISH were valuable to make an accurate subtyping of liposarcomas as well as to differentiate WDLPS from benign lipomatous tumor.
Abstract
Background: The amplification of murine double minutes (MDM2) is the primary feature of well-differentiated liposarcomas (WDLPS) and dedifferentiated liposarcomas (DDLPS), while DDIT3 rearrangement is the main one of myxoid liposarcomas (MLPS). Our aim was to evaluate the added value of MDM2 amplification and DDIT3 rearrangement in making a diagnosis and classifying lipogenic tumors. Methods: Eighty-two cases of liposarcoma and 60 lipomas diagnosed between 1995 and 2010 were analysed for MDM2 amplification and DDIT3 rearrangement using a fluorescence in situ hybridization (FISH). The subtypes of liposarcoma were reclassified according to the molecular results, whose results were reviewed with an analysis of the relevant histologic and immunohistochemical findings. Results: One case of lipoma (1.67%) was reclassified as a WDLPS. Of the liposarcomas, 13.4% (16/82) were reclassified after the molecular testing. Five cases of MLPS were reclassified as four cases of DDLPS and one case of myxoid lipoma. Two cases of WDLPS were reclassified as one case of spindle cell lipoma and another case of myxofibrosarcoma. Four cases of DDLPS were reclassified as two cases of leiomyosarcoma, one case of angiomyolipoma and another case of fibroinflammatory lesion. Of the six cases of pleomorphic liposarcoma, five were reclassified as DDLPS. Conclusions: In our series, a critical revision of diagnosis was found at a rate of 3.5% (5/142) after a review of the lipomatous lesions. The uses of molecular testing by MDM2 and DDIT3 FISH were valuable to make an accurate subtyping of liposarcomas as well as to differentiate WDLPS from benign lipomatous tumor.
참고문헌 (16)
- Fletcher CD, "World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone" (2002), IARC Press
- Mariño-Enríquez A, "Dedifferentiated liposarcoma with “homologous” lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria", Am J Surg Pathol, 34, pp.1122~1131 (2010)
- Dal Cin P, "Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors", Cancer Genet Cytogenet, 68, pp.85~90 (1993)
- Pedeutour F, "Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma", Genes Chromosomes Cancer, 10, pp.85~94 (1994)
- Pedeutour F, "Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors", Genes Chromosomes Cancer, 24, pp.30~41 (1999)
- Dei Tos AP, "Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours", J Pathol, 190, pp.531~536 (2000)
- Sandberg AA., "Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma", Cancer Genet Cytogenet, 155, pp.1~24 (2004)
- Momand J, "The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation", Cell, 69, pp.1237~1245 (1992)
- Aleixo PB, "Can MDM2 and CDK4 make the diagnosis of well differentiated", dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours, 2009, pp.62, 1127~1135
- Binh MB, "MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data", Am J Surg Pathol, 29, pp.1340~1347 (2005)
- Sirvent N, "Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR", Am J Surg Pathol, 31, pp.1476~1489 (2007)
- Willmore-Payne C, "Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe", Arch Pathol Lab Med, 132, pp.952~957 (2008)
- Macarenco RS, "Retroperitoneal lipomatous tumors without cytologic atypia: are they lipomas? A clinicopathologic and molecular study of 19 cases", Am J Surg Pathol, 33, pp.1470~1476 (2009)
- Pilotti S, "Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22", J Pathol, 185, pp.188~190 (1998)
- de Vreeze RS, "Primary retroperitoneal myxoid", round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis, 2009, pp.22, 223~231
- de Vreeze RS, "Added value of molecular biological analysis in diagnosis and clinical management of liposarcoma: a 30-year single-institution experience", Ann Surg Oncol, 17, pp.686~693 (2010)